CA-125: a biomarker put to the test

Charlie Schmidt
Journal of the National Cancer Institute · 2011 · doi:10.1093/jnci/djr344 · PMID:21852262
other OA: bronze public-domain-us
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-12 ⓘ

This review evaluates the clinical utility of CA-125 as a biomarker for ovarian cancer detection, monitoring, and prognosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Biomarkers, Tumor CA-125 Antigen Mass Screening Ovarian Neoplasms Ovarian Neoplasms Biomarkers Biomarkers Biomarkers, Tumor CA-125 Antigen Clinical Trials as Topic Endometriosis Endometriosis False Positive Reactions Female Gynecologic Surgical Procedures Gynecologic Surgical Procedures Humans Mass Screening Ovarian Diseases Ovarian Diseases

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-04T06:08:07.471253+00:00
pubmed
last seen: 2026-05-13T22:16:35.898691+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine